Ms. Johnson founded Daré Bioscience Operations, Inc. in 2015 and has served as President, CEO and a member of the Board of Directors since its inception and following its business combination with Cerulean Pharma Inc. on July 19, 2017, when the Company was renamed Daré Bioscience, Inc. Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare.
Previously, Ms. Johnson served as President of WomanCare Global Trading, a specialty pharmaceutical company in female reproductive healthcare with commercial product distribution in over 100 countries, from October of 2014 to May of 2015, and Chief Financial Officer and Chief Operating Officer from July 2013 to October 2014. Ms. Johnson provided financial consulting services to the WomanCare Global family of companies, including the United Kingdom-based non-profit division, from November 2012 to July 2013. From 2002 until its sale in 2010, Ms. Johnson served as Chief Financial Officer of Cypress Bioscience, Inc., a publicly-traded pharmaceutical company, and in addition served as its Chief Operating Officer from 2008 until its sale in 2010. Ms. Johnson began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on their recombinant factor VIII program, and later held marketing and sales positions with Advanced Tissue Sciences and Clonetics Corporation.
Ms. Johnson currently serves on the boards of Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer; the YWCA of San Diego County as Past President, Athena San Diego, BIOCOM, and the Clearity Foundation as incoming Chair. Additionally. Ms. Johnson serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International.
Ms. Johnson has a Masters of International Management degree with honors from the American Graduate School of International Management (Thunderbird), a MSc in Biochemical Engineering from the University of London, University College London and a BSc in Biomedical Engineering from Tulane University, where she graduated magna cum laude.